Loading...
Header Logo
Keywords
Last Name
Institution

Mohit Khera

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Urology
DivisionUrology
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lopez DS, Huang D, Tsilidis KK, Khera M, Williams SB, Urban RJ, Panagiotou OA, Kuo YF, Baillargeon J, Farias A, Krause T. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf). 2019 Sep 09. PMID: 31498469.
      View in: PubMed
    2. Khera M, Sadeghi-Nejad H. Editorial Comment. J Urol. 2019 09; 202(3):610. PMID: 31199177.
      View in: PubMed
    3. Khera M, Bivalacqua T, Goldstein I, Albersen M. An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? Eur Urol Focus. 2019 Jul; 5(4):536-538. PMID: 31196678.
      View in: PubMed
    4. Salonia A, Rastrelli G, Hackett G, Seminara SB, Huhtaniemi IT, Rey RA, Hellstrom WJG, Palmert MR, Corona G, Dohle GR, Khera M, Chan YM, Maggi M. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019 May 30; 5(1):38. PMID: 31147553.
      View in: PubMed
    5. Bates JN, Pastuszak AW, Khera M. Effect of Body Weight on Sexual Function in Men and Women. Curr Sex Health Rep. 2019 Mar; 11(1):52-59. PMID: 31576197.
      View in: PubMed
    6. Scovell JM, Khera M. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male. Eur Urol Focus. 2018 04; 4(3):321-323. PMID: 30131284.
      View in: PubMed
    7. Rodriguez KM, Pastuszak AW, Khera M. The Role of Testosterone Therapy in the Setting of Prostate Cancer. Curr Urol Rep. 2018 Jun 30; 19(8):67. PMID: 29961247.
      View in: PubMed
    8. Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW. Erectile Dysfunction: AUA Guideline. J Urol. 2018 09; 200(3):633-641. PMID: 29746858.
      View in: PubMed
    9. Lopez DS, Advani S, Qiu X, Tsilidis KK, Khera M, Kim J, Canfield S. Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012. Aging Male. 2019 Mar; 22(1):45-54. PMID: 29692226.
      View in: PubMed
    10. Miner M, Morgentaler A, Khera M, Traish AM. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 07; 89(1):3-10. PMID: 29486065.
      View in: PubMed
    11. Khera M, Bella A, Karpman E, Brant W, Christine B, Kansas B, Jones L, Kohler T, Bennett N, Rhee E, Henry G. Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression. J Sex Med. 2018 05; 15(5):786-788. PMID: 29653913.
      View in: PubMed
    12. Grabner M, Hepp Z, Raval A, Tian F, Khera M. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. J Sex Med. 2018 02; 15(2):148-158. PMID: 29425664.
      View in: PubMed
    13. Sigalos JT, Pastuszak AW, Khera M. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes. Med Clin North Am. 2018 Mar; 102(2):361-372. PMID: 29406064.
      View in: PubMed
    14. Bennett N, Henry G, Karpman E, Brant W, Jones L, Khera M, Kohler T, Christine B, Rhee E, Kansas B, Bella AJ. Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study. Transl Androl Urol. 2017 Dec; 6(6):1167-1174. PMID: 29354506.
      View in: PubMed
    15. Lo EM, Rodriguez KM, Pastuszak AW, Khera M. Alternatives to Testosterone Therapy: A Review. Sex Med Rev. 2018 01; 6(1):106-113. PMID: 29174957.
      View in: PubMed
    16. Rizk PJ, Kohn TP, Pastuszak AW, Khera M. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr Opin Urol. 2017 Nov; 27(6):511-515. PMID: 28816715.
      View in: PubMed
    17. Song W, Soni V, Soni S, Khera M. Testosterone inhibits the growth of prostate cancer xenografts in nude mice. BMC Cancer. 2017 Sep 07; 17(1):635. PMID: 28877700.
      View in: PubMed
    18. Mobley DF, Khera M, Baum N. Recent advances in the treatment of erectile dysfunction. Postgrad Med J. 2017 Nov; 93(1105):679-685. PMID: 28751439.
      View in: PubMed
    19. Yafi FA, Haney NM, Anaissie J, DeLay KJ, Trost L, Khera M, Hellstrom WJG. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology. 2017 Aug; 106:87-95. PMID: 28479477.
      View in: PubMed
    20. Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):285-296. PMID: 28262099.
      View in: PubMed
    21. Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):297-315. PMID: 28262100.
      View in: PubMed
    22. Sanchez E, Pastuszak AW, Khera M. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol. 2017 Feb; 6(1):28-36. PMID: 28217448.
      View in: PubMed
    23. Grabner M, Bodhani A, Khandelwal N, Palli S, Bonine N, Khera M. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population. J Sex Med. 2017 01; 14(1):88-97. PMID: 27939338.
      View in: PubMed
    24. Pastuszak AW, Rodriguez KM, Nguyen TM, Khera M. Testosterone therapy and prostate cancer. Transl Androl Urol. 2016 Dec; 5(6):909-920. PMID: 28078223.
      View in: PubMed
    25. Khera M, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Salonia A. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 12; 13(12):1787-1804. PMID: 27914560.
      View in: PubMed
    26. Podlasek CA, Mulhall J, Davies K, Wingard CJ, Hannan JL, Bivalacqua TJ, Musicki B, Khera M, González-Cadavid NF, Burnett AL. Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction. J Sex Med. 2016 08; 13(8):1183-98. PMID: 27436075.
      View in: PubMed
    27. Khera M. Editorial Comment on "Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial". J Sex Med. 2016 08; 13(8):1243-4. PMID: 27436078.
      View in: PubMed
    28. Khera M, Broderick GA, Carson CC, Dobs AS, Faraday MM, Goldstein I, Hakim LS, Hellstrom WJ, Kacker R, Köhler TS, Mills JN, Miner M, Sadeghi-Nejad H, Seftel AD, Sharlip ID, Winters SJ, Burnett AL. Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 07; 91(7):908-26. PMID: 27343020.
      View in: PubMed
    29. Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, McCullough A, Torres LO, Khera M. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 Apr; 13(4):465-88. PMID: 27045254.
      View in: PubMed
    30. Khera M. Testosterone Therapies. Urol Clin North Am. 2016 May; 43(2):185-93. PMID: 27132575.
      View in: PubMed
    31. Khera M. Male hormones and men's quality of life. Curr Opin Urol. 2016 Mar; 26(2):152-7. PMID: 26765046.
      View in: PubMed
    32. Khera M. Testosterone is Protective against Cardiac Disease: Pro. J Urol. 2016 04; 195(4 Pt 1):831-2. PMID: 26807929.
      View in: PubMed
    33. Khera M. Changing paradigm of men's health. Indian J Urol. 2016 Jan-Mar; 32(1):5. PMID: 26941487.
      View in: PubMed
    34. Dean J, Maggi M, de Boer BJ, Hellstrom W, Khera M, Kim ED, McCullough A, Wu F, Zitzmann M. Diagnosing secondary hypogonadism: important consequences for fertility and reversibility. BJU Int. 2016 Apr; 117(4):552-4. PMID: 26360119.
      View in: PubMed
    35. Hakky T, Lentz A, Sadeghi-Nejad H, Khera M. The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. J Sex Med. 2015 Nov; 12 Suppl 7:464-7. PMID: 26565579.
      View in: PubMed
    36. Khera M. Testosterone Replacement in Men with Treated and Untreated Prostate Cancer. Sex Med Rev. 2013 Oct; 1(3):143-149. PMID: 27784553.
      View in: PubMed
    37. Khera M. Testosterone Therapy for Female Sexual Dysfunction. Sex Med Rev. 2015 Jul; 3(3):137-144. PMID: 27784606.
      View in: PubMed
    38. Song W, Soni V, Khera M. Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer. Asian J Androl. 2015 Sep-Oct; 17(5):807-10. PMID: 25761834.
      View in: PubMed
    39. Henry GD, Karpman E, Brant W, Christine B, Kansas BT, Khera M, Jones L, Kohler T, Bennett N, Rhee E, Eisenhart E, Bella AJ. The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data. J Urol. 2016 Feb; 195(2):427-33. PMID: 26292043.
      View in: PubMed
    40. Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, Lipshultz LI. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med. 2015 Sep; 3(3):165-73. PMID: 26468380.
      View in: PubMed
    41. Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, Khera M, Kirkby E, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW, Burnett AL. Peyronie's Disease: AUA Guideline. J Urol. 2015 Sep; 194(3):745-53. PMID: 26066402.
      View in: PubMed
    42. Pastuszak AW, Khanna A, Badhiwala N, Morgentaler A, Hult M, Conners WP, Sarosdy MF, Yang C, Carrion R, Lipshultz LI, Khera M. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6. PMID: 26025500.
      View in: PubMed
    43. Khera M, Albersen M, Mulhall JP. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May; 12(5):1105-6. PMID: 25974235.
      View in: PubMed
    44. Ferrati S, Nicolov E, Zabre E, Geninatti T, Shirkey BA, Hudson L, Hosali S, Crawley M, Khera M, Palapattu G, Grattoni A. The nanochannel delivery system for constant testosterone replacement therapy. J Sex Med. 2015 Jun; 12(6):1375-80. PMID: 25930087.
      View in: PubMed
    45. Pastuszak AW, Hyman DA, Yadav N, Godoy G, Lipshultz LI, Araujo AB, Khera M. Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis. J Sex Med. 2015 Apr; 12(4):975-84. PMID: 25728904.
      View in: PubMed
    46. Khera M. Controversies in testosterone supplementation therapy. Asian J Androl. 2015 Mar-Apr; 17(2):175-6. PMID: 25652639.
      View in: PubMed
    47. Morgentaler A, Miner MM, Caliber M, Guay AT, Khera M, Traish AM. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51. PMID: 25636998.
      View in: PubMed
    48. Traish AM, Morgentaler A, Khera M. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2. PMID: 25526553.
      View in: PubMed
    49. Song W, Khera M. Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro. Asian J Androl. 2014 Nov-Dec; 16(6):864-8. PMID: 24923459.
      View in: PubMed
    50. Ferrati S, Nicolov E, Bansal S, Zabre E, Geninatti T, Ziemys A, Hudson L, Ferrari M, Goodall R, Khera M, Palapattu G, Grattoni A. Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater. 2015 Feb 18; 4(3):446-51. PMID: 25274059.
      View in: PubMed
    51. Goldstein AT, Belkin ZR, Krapf JM, Song W, Khera M, Jutrzonka SL, Kim NN, Burrows LJ, Goldstein I. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014 Nov; 11(11):2764-71. PMID: 25187224.
      View in: PubMed
    52. Dupree JM, Langille GM, Khera M, Lipshultz LI. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30. PMID: 25069737.
      View in: PubMed
    53. Trost LW, Khera M. Alternative treatment modalities for the hypogonadal patient. Curr Urol Rep. 2014 Jul; 15(7):417. PMID: 24817260.
      View in: PubMed
    54. Morgentaler A, Khera M, Maggi M, Zitzmann M. Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45. PMID: 24797325.
      View in: PubMed
    55. Khera M, Morgentaler A. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. Eur Urol. 2014 Aug; 66(2):e33. PMID: 24836155.
      View in: PubMed
    56. Carson CC, Khera M. Controversies in the treatment of male hypogonadism. Urology. 2014 Apr; 83(4):957. PMID: 24680460.
      View in: PubMed
    57. Khera M. Patients with testosterone deficit syndrome and depression. Arch Esp Urol. 2013 Sep; 66(7):729-36. PMID: 24047633.
      View in: PubMed
    58. Darouiche RO, Bella AJ, Boone TB, Brock G, Broderick GA, Burnett AL, Carrion R, Carson C, Christine B, Dhabuwala CB, Hakim LS, Henry G, Jones LA, Khera M, Montague DK, Nehra A. North American consensus document on infection of penile prostheses. Urology. 2013 Oct; 82(4):937-42. PMID: 23958508.
      View in: PubMed
    59. Khera M, Crawford D, Morales A, Salonia A, Morgentaler A. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014 Jan; 65(1):115-23. PMID: 24011426.
      View in: PubMed
    60. Soni SD, Song W, West JL, Khera M. Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. J Sex Med. 2013 Aug; 10(8):1915-25. PMID: 23751157.
      View in: PubMed
    61. Karpman E, Sadeghi-Nejad H, Henry G, Khera M, Morey AF. Current opinions on alternative reservoir placement for inflatable penile prosthesis among members of the Sexual Medicine Society of North America. J Sex Med. 2013 Aug; 10(8):2115-20. PMID: 23679798.
      View in: PubMed
    62. Miner MM, Bhattacharya RK, Blick G, Kushner H, Khera M. 12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med. 2013 Mar; 125(2):8-18. PMID: 23816767.
      View in: PubMed
    63. Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Postgrad Med. 2013 Mar; 125(2):19-29. PMID: 23816768.
      View in: PubMed
    64. Pastuszak AW, Pearlman AM, Lai WS, Godoy G, Sathyamoorthy K, Liu JS, Miles BJ, Lipshultz LI, Khera M. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44. PMID: 23395803.
      View in: PubMed
    65. Kim ED, Crosnoe L, Bar-Chama N, Khera M, Lipshultz LI. The treatment of hypogonadism in men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24. PMID: 23219010.
      View in: PubMed
    66. Moskovic DJ, Araujo AB, Lipshultz LI, Khera M. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013 Feb; 10(2):562-9. PMID: 23035926.
      View in: PubMed
    67. Khera M. Testosterone replacement in normal and pathologic prostate. Horm Mol Biol Clin Investig. 2012 Oct; 11(3):347-53. PMID: 25436694.
      View in: PubMed
    68. Bhattacharya RK, Khera M, Blick G, Kushner H, Miner MM. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging. 2012; 7:321-30. PMID: 22956867.
      View in: PubMed
    69. Blick G, Khera M, Bhattacharya RK, Nguyen D, Kushner H, Miner MM. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS). Pain Med. 2012 May; 13(5):688-98. PMID: 22536837.
      View in: PubMed
    70. Pastuszak AW, Mittakanti H, Liu JS, Gomez L, Lipshultz LI, Khera M. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37. PMID: 22403285.
      View in: PubMed
    71. McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(®)) insertion. J Sex Med. 2012 Feb; 9(2):594-601. PMID: 22240203.
      View in: PubMed
    72. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male. 2012 Mar; 15(1):14-21. PMID: 22092151.
      View in: PubMed
    73. Bhattacharya RK, Khera M, Blick G, Kushner H, Nguyen D, Miner MM. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011 Nov 01; 11:18. PMID: 22044661.
      View in: PubMed
    74. Moskovic DJ, Freundlich RE, Yazdani P, Lipshultz LI, Khera M. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3. PMID: 21940986.
      View in: PubMed
    75. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 Nov; 8(11):3204-13. PMID: 21834870.
      View in: PubMed
    76. Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011 Sep; 186(3):1005-11. PMID: 21788049.
      View in: PubMed
    77. Khera M, Goldstein I. Erectile dysfunction. BMJ Clin Evid. 2011 Jun 29; 2011. PMID: 21711956.
      View in: PubMed
    78. Gittens P, Moskovic DJ, Avila D, Chandrashekar A, Khera M, Lipshultz LI. Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. J Sex Med. 2011 Jul; 8(7):1996-2001. PMID: 21569210.
      View in: PubMed
    79. Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011 May; 123(3):17-27. PMID: 21566412.
      View in: PubMed
    80. Morgentaler A, Lipshultz LI, Bennett R, Sweeney M, Avila D, Khera M. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60. PMID: 21334649.
      View in: PubMed
    81. Lin YH, Kim JJ, Stein NB, Khera M. Malignant priapism secondary to metastatic prostate cancer: a case report and review of literature. Rev Urol. 2011; 13(2):90-4. PMID: 21935340.
      View in: PubMed
    82. Moskovic DJ, Pastuszak AW, Lipshultz LI, Khera M. Revision of penile prosthesis surgery after use of penile traction therapy to increase erect penile length: case report and review of the literature. J Sex Med. 2011 Feb; 8(2):607-11. PMID: 21091884.
      View in: PubMed
    83. Khera M. Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep. 2010 Nov; 11(6):393-9. PMID: 20838944.
      View in: PubMed
    84. Moskovic DJ, Mohamed O, Sathyamoorthy K, Miles BJ, Link RE, Lipshultz LI, Khera M. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65. PMID: 20819141.
      View in: PubMed
    85. Weedin JW, Khera M, Lipshultz LI. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol. 2010 Jun; 183(6):2309-15. PMID: 20400156.
      View in: PubMed
    86. Weedin JW, Khera M, Lipshultz LI. Reply by authors. J Urol. 2010 Jun; 183(6):2315. PMID: 20400155.
      View in: PubMed
    87. Bechara CF, Weakley SM, Kougias P, Athamneh H, Duffy P, Khera M, Kobayashi K, Lin PH. Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular. 2009 Nov-Dec; 17 Suppl 3:S129-36. PMID: 19919803.
      View in: PubMed
    88. Khera M, Grober ED, Najari B, Colen JS, Mohamed O, Lamb DJ, Lipshultz LI. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170. PMID: 19207277.
      View in: PubMed
    89. Khera M. Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men. J Sex Med. 2009 Mar; 6 Suppl 3:234-8. PMID: 19207279.
      View in: PubMed
    90. Khera M, Lipshultz LI. Evolving approach to the varicocele. Urol Clin North Am. 2008 May; 35(2):183-9, viii. PMID: 18423239.
      View in: PubMed
    91. Khera M, Lipshultz LI. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi. PMID: 17983894.
      View in: PubMed
    92. Khera M, Boone TB, Salas N, Jett MF, Somogyi GT. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 2007 Feb; 99(2):442-6. PMID: 17313428.
      View in: PubMed
    93. Miles BJ, Khera M. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3. PMID: 16763638.
      View in: PubMed
    94. Khera M, Somogyi GT, Salas NA, Kiss S, Boone TB, Smith CP. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology. 2005 Jul; 66(1):208-12. PMID: 15992889.
      View in: PubMed
    95. Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int. 2004 Dec; 45(7):987-93. PMID: 15337297.
      View in: PubMed
    96. Khera M, Boone TB, Smith CP. Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures. J Urol. 2004 Aug; 172(2):574-5. PMID: 15247734.
      View in: PubMed
    Khera's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description